AEHR TEST SYSTEMS (AEHR) Fundamental Analysis & Valuation

NASDAQ:AEHR • US00760J1088

Current stock price

68.86 USD
+5.7 (+9.02%)
At close:
68.9881 USD
+0.13 (+0.19%)
After Hours:

This AEHR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. AEHR Profitability Analysis

1.1 Basic Checks

  • AEHR had negative earnings in the past year.
  • AEHR had a negative operating cash flow in the past year.
  • In multiple years AEHR reported negative net income over the last 5 years.
  • In multiple years AEHR reported negative operating cash flow during the last 5 years.
AEHR Yearly Net Income VS EBIT VS OCF VS FCFAEHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M 30M

1.2 Ratios

  • AEHR has a Return On Assets of -5.95%. This is in the lower half of the industry: AEHR underperforms 67.83% of its industry peers.
  • The Return On Equity of AEHR (-6.77%) is worse than 63.48% of its industry peers.
Industry RankSector Rank
ROA -5.95%
ROE -6.77%
ROIC N/A
ROA(3y)12.71%
ROA(5y)8.78%
ROE(3y)15.26%
ROE(5y)9.32%
ROIC(3y)N/A
ROIC(5y)N/A
AEHR Yearly ROA, ROE, ROICAEHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 400 600 800

1.3 Margins

  • AEHR's Gross Margin of 33.28% is on the low side compared to the rest of the industry. AEHR is outperformed by 64.35% of its industry peers.
  • In the last couple of years the Gross Margin of AEHR has grown nicely.
  • The Profit Margin and Operating Margin are not available for AEHR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.28%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.48%
GM growth 5Y1.57%
AEHR Yearly Profit, Operating, Gross MarginsAEHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. AEHR Health Analysis

2.1 Basic Checks

  • AEHR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, AEHR has more shares outstanding
  • The number of shares outstanding for AEHR has been increased compared to 5 years ago.
  • AEHR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AEHR Yearly Shares OutstandingAEHR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
AEHR Yearly Total Debt VS Total AssetsAEHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M

2.2 Solvency

  • AEHR has an Altman-Z score of 70.94. This indicates that AEHR is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 70.94, AEHR belongs to the top of the industry, outperforming 97.39% of the companies in the same industry.
  • AEHR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 70.94
ROIC/WACCN/A
WACC11.6%
AEHR Yearly LT Debt VS Equity VS FCFAEHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • AEHR has a Current Ratio of 10.62. This indicates that AEHR is financially healthy and has no problem in meeting its short term obligations.
  • AEHR has a better Current ratio (10.62) than 93.91% of its industry peers.
  • A Quick Ratio of 5.47 indicates that AEHR has no problem at all paying its short term obligations.
  • AEHR has a better Quick ratio (5.47) than 80.87% of its industry peers.
Industry RankSector Rank
Current Ratio 10.62
Quick Ratio 5.47
AEHR Yearly Current Assets VS Current LiabilitesAEHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. AEHR Growth Analysis

3.1 Past

  • AEHR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -109.00%.
  • AEHR shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 243890.10% yearly.
  • Looking at the last year, AEHR shows a very negative growth in Revenue. The Revenue has decreased by -10.95% in the last year.
  • Measured over the past years, AEHR shows a very strong growth in Revenue. The Revenue has been growing by 21.48% on average per year.
EPS 1Y (TTM)-109%
EPS 3Y-27.89%
EPS 5Y243890.1%
EPS Q2Q%-171.43%
Revenue 1Y (TTM)-10.95%
Revenue growth 3Y5.07%
Revenue growth 5Y21.48%
Sales Q2Q%-43.68%

3.2 Future

  • AEHR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.92% yearly.
  • The Revenue is expected to grow by 18.08% on average over the next years. This is quite good.
EPS Next Y-186.7%
EPS Next 2Y-7.8%
EPS Next 3Y20.92%
EPS Next 5YN/A
Revenue Next Year-21.16%
Revenue Next 2Y16.45%
Revenue Next 3Y18.08%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
AEHR Yearly Revenue VS EstimatesAEHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M 80M 100M
AEHR Yearly EPS VS EstimatesAEHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 1

More info and screens

Find the best growth stocksShow best growing peers

1

4. AEHR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for AEHR. In the last year negative earnings were reported.
  • The Price/Forward Earnings ratio is 540.08, which means the current valuation is very expensive for AEHR.
  • Based on the Price/Forward Earnings ratio, AEHR is valued a bit more expensive than the industry average as 64.35% of the companies are valued more cheaply.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.68, AEHR is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 540.08
AEHR Price Earnings VS Forward Price EarningsAEHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 -200 400 -400 -600

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AEHR Per share dataAEHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • AEHR's earnings are expected to grow with 20.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.8%
EPS Next 3Y20.92%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AEHR Dividend Analysis

5.1 Amount

  • AEHR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AEHR Fundamentals: All Metrics, Ratios and Statistics

AEHR TEST SYSTEMS

NASDAQ:AEHR (4/9/2026, 8:11:04 PM)

After market: 68.9881 +0.13 (+0.19%)

68.86

+5.7 (+9.02%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)04-07
Earnings (Next)07-06
Inst Owners70.95%
Inst Owner Change0%
Ins Owners5.98%
Ins Owner Change1.85%
Market Cap2.11B
Revenue(TTM)58.97M
Net Income(TTM)-8.86M
Analysts80
Price Target37.06 (-46.18%)
Short Float %15.41%
Short Ratio2.85
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-8.29%
Min Revenue beat(2)-16.39%
Max Revenue beat(2)-0.19%
Revenue beat(4)1
Avg Revenue beat(4)-5.59%
Min Revenue beat(4)-16.39%
Max Revenue beat(4)1.05%
Revenue beat(8)3
Avg Revenue beat(8)-3.26%
Revenue beat(12)6
Avg Revenue beat(12)-1.32%
Revenue beat(16)8
Avg Revenue beat(16)1.18%
PT rev (1m)47.3%
PT rev (3m)41.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-450%
EPS NY rev (1m)0%
EPS NY rev (3m)-308.33%
Revenue NQ rev (1m)0.46%
Revenue NQ rev (3m)-33.23%
Revenue NY rev (1m)0.21%
Revenue NY rev (3m)-19.46%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 540.08
P/S 39.61
P/FCF N/A
P/OCF N/A
P/B 16.13
P/tB 19.19
EV/EBITDA N/A
EPS(TTM)-0.09
EYN/A
EPS(NY)0.13
Fwd EY0.19%
FCF(TTM)-0.38
FCFYN/A
OCF(TTM)-0.17
OCFYN/A
SpS1.74
BVpS4.27
TBVpS3.59
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -5.95%
ROE -6.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.28%
FCFM N/A
ROA(3y)12.71%
ROA(5y)8.78%
ROE(3y)15.26%
ROE(5y)9.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.48%
GM growth 5Y1.57%
F-Score4
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 226.79%
Cap/Sales 11.89%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.62
Quick Ratio 5.47
Altman-Z 70.94
F-Score4
WACC11.6%
ROIC/WACCN/A
Cap/Depr(3y)210.71%
Cap/Depr(5y)168.36%
Cap/Sales(3y)3.9%
Cap/Sales(5y)2.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-109%
EPS 3Y-27.89%
EPS 5Y243890.1%
EPS Q2Q%-171.43%
EPS Next Y-186.7%
EPS Next 2Y-7.8%
EPS Next 3Y20.92%
EPS Next 5YN/A
Revenue 1Y (TTM)-10.95%
Revenue growth 3Y5.07%
Revenue growth 5Y21.48%
Sales Q2Q%-43.68%
Revenue Next Year-21.16%
Revenue Next 2Y16.45%
Revenue Next 3Y18.08%
Revenue Next 5YN/A
EBIT growth 1Y-1316.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-243.51%
EBIT Next 3Y87.64%
EBIT Next 5YN/A
FCF growth 1Y-282.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-166.21%
OCF growth 3YN/A
OCF growth 5YN/A

AEHR TEST SYSTEMS / AEHR Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for AEHR TEST SYSTEMS?

ChartMill assigns a fundamental rating of 4 / 10 to AEHR.


Can you provide the valuation status for AEHR TEST SYSTEMS?

ChartMill assigns a valuation rating of 1 / 10 to AEHR TEST SYSTEMS (AEHR). This can be considered as Overvalued.


Can you provide the profitability details for AEHR TEST SYSTEMS?

AEHR TEST SYSTEMS (AEHR) has a profitability rating of 1 / 10.


Can you provide the financial health for AEHR stock?

The financial health rating of AEHR TEST SYSTEMS (AEHR) is 8 / 10.


What is the expected EPS growth for AEHR TEST SYSTEMS (AEHR) stock?

The Earnings per Share (EPS) of AEHR TEST SYSTEMS (AEHR) is expected to decline by -186.7% in the next year.